Anne M. Filppula

1.6k total citations
37 papers, 1.1k citations indexed

About

Anne M. Filppula is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Anne M. Filppula has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 13 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Anne M. Filppula's work include Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Anne M. Filppula is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Anne M. Filppula collaborates with scholars based in Finland, China and United States. Anne M. Filppula's co-authors include Janne T. Backman, Pertti J. Neuvonen, Mikko Niemi, Aleksi Tornio, Jouko Laitila, Mikko Neuvonen, Tuija Tapaninen, Tommi Nyrönen, Li Wang and Hongbo Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Anne M. Filppula

35 papers receiving 1.1k citations

Peers

Anne M. Filppula
Gang Luo China
Leslie J. Dickmann United States
Hyeong‐Seok Lim South Korea
M Hroch Czechia
Lisa J. Christopher United States
Kathleen Köck United States
Gang Luo China
Anne M. Filppula
Citations per year, relative to Anne M. Filppula Anne M. Filppula (= 1×) peers Gang Luo

Countries citing papers authored by Anne M. Filppula

Since Specialization
Citations

This map shows the geographic impact of Anne M. Filppula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Filppula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Filppula more than expected).

Fields of papers citing papers by Anne M. Filppula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Filppula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Filppula. The network helps show where Anne M. Filppula may publish in the future.

Co-authorship network of co-authors of Anne M. Filppula

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Filppula. A scholar is included among the top collaborators of Anne M. Filppula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Filppula. Anne M. Filppula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Li, Lu Fan, Anne M. Filppula, et al.. (2025). Dual physiological responsive structural color hydrogel particles for wound repair. Bioactive Materials. 46. 494–502. 9 indexed citations
3.
Filppula, Anne M., et al.. (2025). Automated 3D printing of pediatric furosemide tablets: A personalized medicine approach using semi-solid extrusion and NIR monitoring. European Journal of Pharmaceutical Sciences. 214. 107269–107269.
4.
Lin, Xiang, Anne M. Filppula, Yuanjin Zhao, Luoran Shang, & Hongbo Zhang. (2025). Mechanically regulated microcarriers with stem cell loading for skin photoaging therapy. Bioactive Materials. 46. 448–456. 2 indexed citations
5.
Wang, Yonghui, Chang Liu, Xiaodong Ma, et al.. (2024). Encapsulated mitochondria to reprogram the metabolism of M2-type macrophages for anti-tumor therapy. Nanoscale. 16(45). 20925–20939. 3 indexed citations
6.
Neuvonen, Mikko, et al.. (2024). Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes – detailed studies on CYP3A inhibitors. European Journal of Pharmaceutical Sciences. 198. 106735–106735. 5 indexed citations
7.
Engström, Marica T., Mikko Neuvonen, Troels K. Bergmann, et al.. (2024). Candesartan Has No Clinically Meaningful Effect on the Plasma Concentrations of Cytochrome P450 2C8 Substrate Repaglinide in Humans. Drug Metabolism and Disposition. 52(12). 1388–1395. 2 indexed citations
8.
Wang, Li, et al.. (2024). Self-Healing Dynamic Hydrogel Microparticles with Structural Color for Wound Management. Nano-Micro Letters. 16(1). 232–232. 36 indexed citations
9.
Filppula, Anne M., et al.. (2024). Automated extrusion-based dispensing: Personalized dosing and quality control of clopidogrel tablets for pediatric care. European Journal of Pharmaceutical Sciences. 204. 106967–106967. 8 indexed citations
10.
Lin, Xiang, Lu Fan, Li Wang, et al.. (2023). Fabricating biomimetic materials with ice‐templating for biomedical applications. SHILAP Revista de lepidopterología. 2(3). e20230017–e20230017. 25 indexed citations
11.
Filppula, Anne M., et al.. (2023). Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?. British Journal of Clinical Pharmacology. 89(7). 2309–2315. 8 indexed citations
13.
Deng, Feng, Mikko Neuvonen, Christoph Wenzel, et al.. (2021). Comparative Hepatic and Intestinal Efflux Transport of Statins. Drug Metabolism and Disposition. 49(9). 750–759. 48 indexed citations
14.
Filppula, Anne M., Feng Deng, Jenni Viinamäki, et al.. (2021). Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins. Drug Metabolism and Disposition. 49(8). 658–667. 26 indexed citations
15.
Filppula, Anne M., Terhi Launiainen, Jenni Viinamäki, et al.. (2019). Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8. Drug Metabolism and Disposition. 47(4). 436–443. 11 indexed citations
16.
Filppula, Anne M., et al.. (2019). Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations. Scientific Reports. 9(1). 5850–5850. 15 indexed citations
17.
Filppula, Anne M., Mikko Neuvonen, E. Katriina Tarkiainen, et al.. (2017). Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions. Drug Metabolism and Disposition. 46(2). 141–150. 24 indexed citations
18.
Tornio, Aleksi, Anne M. Filppula, Mikko Neuvonen, et al.. (2014). Glucuronidation Converts Clopidogrel to a Strong Time-Dependent Inhibitor of CYP2C8: A Phase II Metabolite as a Perpetrator of Drug–Drug Interactions. Clinical Pharmacology & Therapeutics. 96(4). 498–507. 114 indexed citations
19.
Filppula, Anne M., Jouko Laitila, Pertti J. Neuvonen, & Janne T. Backman. (2011). Potent mechanism‐based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. British Journal of Pharmacology. 165(8). 2787–2798. 79 indexed citations
20.
Filppula, Anne M., Jouko Laitila, Pertti J. Neuvonen, & Janne T. Backman. (2011). Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations. Drug Metabolism and Disposition. 39(5). 904–911. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026